For decades, depression treatment has followed a familiar and often frustrating pattern. Patients are prescribed an antidepressant, asked to wait several weeks, and then—if symptoms persist—the dose is adjusted or a new medication is tried. For many people, this process repeats over and over again, sometimes for years.

When relief doesn’t come, patients are often told to “try one more medication” or “give it more time.” Over time, this can lead to exhaustion, self-doubt, and a dangerous belief that nothing will ever work.

At Radiant Minds, we see this story far too often. And it’s why we want to be clear about one important truth:

Spravato® (esketamine) is not a last resort. It is a smarter, science-driven option for people whose depression does not respond to traditional treatments.

Why the “Last Resort” Label Is Misleading

Many patients delay considering Spravato® because they believe it should only be used after “everything else” has failed. This belief is understandable—but outdated.

Spravato® was not designed as a backup plan. It was developed specifically for Treatment-Resistant Depression (TRD)—a condition where standard antidepressants do not produce meaningful improvement, even after multiple attempts.

TRD is not rare. Studies suggest that up to one-third of people with depression do not respond adequately to traditional antidepressants. Continuing the same approach over and over does not always lead to better results. In fact, it can delay recovery.

Choosing Spravato® earlier is not giving up—it is choosing a treatment that works differently and more precisely for certain brains.

Why the “Last Resort” Label Is Misleading

Most antidepressants on the market today target serotonin, dopamine, or norepinephrine. While these medications help many people, they don’t address all the biological factors involved in depression.

Long-term or severe depression can disrupt:

  • Neural connectivity
  • Brain plasticity

  • Stress-response systems

  • Emotional regulation circuits

In these cases, simply increasing serotonin may not be enough.

Patients often report:

  • Emotional numbness rather than relief

  • Minimal improvement after weeks or months

  • Loss of appetite or unwanted weight changes

  • Fatigue, brain fog, or worsening anxiety

When this happens, the issue is not effort or willpower. The brain may simply require a different mechanism of treatment.

How Spravato® Changes the Approach

Spravato® works on the glutamate system, which plays a major role in how brain cells communicate and adapt. This system is directly involved in learning, memory, and emotional processing.

By targeting glutamate, Spravato® helps:

  • Restore weakened neural connections

  • Improve communication between brain regions

  • Support brain plasticity and healing

  • Produce faster symptom relief

This is why many patients experience improvement within hours or days, rather than waiting weeks.

Instead of masking symptoms, Spravato® helps the brain rebuild.

Why Waiting Can Make Recovery Harder

Depression is not static—it evolves over time. When symptoms persist untreated or poorly treated, the brain can become increasingly rigid in its negative patterns.

Waiting too long to change treatment strategies can:

  • Prolong suffering

  • Increase emotional exhaustion

  • Reduce confidence in treatment
  • Increase risk during depressive crises

Choosing Spravato® earlier—when appropriate—can interrupt this cycle and create momentum toward recovery.

At Radiant Minds, we evaluate each patient carefully to determine when it makes sense to consider Spravato®, rather than defaulting to endless medication trials.

A Smarter Decision, Not a Desperate One

There is nothing “extreme” about choosing a treatment designed for your condition.

Spravato® is:

  • FDA-approved

  • Backed by extensive clinical research

  • Used in leading psychiatric centers nationwide

  • Administered under strict medical supervision

  • It represents progress in mental health care—not a last-ditch option

Choosing Spravato® earlier—when appropriate—can interrupt this cycle and create momentum toward recovery.

At Radiant Minds, we evaluate each patient carefully to determine when it makes sense to consider Spravato®, rather than defaulting to endless medication trials.

Our Philosophy at Radiant Minds

We believe patients deserve:

  • Clear explanations

  • Science-backed options

  • Honest recommendations

  • A treatment plan that respects their time, energy, and emotional well-being

If you’ve been cycling through medications with little relief, it may not be that you haven’t tried enough—it may be that it’s time to try something different.

Spravato® is not about giving up. It’s about choosing a smarter path forward.

For decades, depression treatment has followed a familiar and often frustrating pattern. Patients are prescribed an antidepressant, asked to wait several weeks, and then—if symptoms persist—the dose is adjusted or a new medication is tried. For many people, this process repeats over and over again, sometimes for years.

When relief doesn’t come, patients are often told to “try one more medication” or “give it more time.” Over time, this can lead to exhaustion, self-doubt, and a dangerous belief that nothing will ever work.

At Radiant Minds, we see this story far too often. And it’s why we want to be clear about one important truth:

Spravato® (esketamine) is not a last resort. It is a smarter, science-driven option for people whose depression does not respond to traditional treatments.